Michigan
Alzheimer's disease clinical trials in Michigan
12 Alzheimer's disease studies are recruiting participants at sites in 15 cities across Michigan as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Michigan city with a recruiting study
Farmington Hills (6), Ann Arbor (1), Bloomfield Hills (1), Bloomfield Township (1), Corunna (1), Detroit (1), Flint (1), Gaylord (1), Grand Rapids (1), Midland (1), Prudenville (1), Sault Ste. Marie (1), Southfield (1), Traverse City (1), Troy (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Michigan
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Farmington Hills
- Registry record
- NCT07177352 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Bloomfield Hills · Troy
- Registry record
- NCT07011732 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Farmington Hills
- Registry record
- NCT07589595 · updated
A Study of LY3439539 in Participants With Alzheimer's Disease
- Phase 1
- Ages 50 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Farmington Hills
- Registry record
- NCT07598370 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Southfield
- Registry record
- NCT07602582 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Recruiting in
- Bloomfield Township
- Registry record
- NCT06585787 · updated
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Phase 4
- Ages 50 and older
- All sexes
- Sponsor
- Alpha Cognition, Inc
- Recruiting in
- Farmington Hills
- Registry record
- NCT07633470 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Farmington Hills
- Registry record
- NCT06976203 · updated
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- No phase
- Ages 70 and older
- All sexes
- Sponsor
- University of Michigan
- Recruiting in
- Ann Arbor
- Registry record
- NCT05929703 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Recruiting in
- Detroit
- Registry record
- NCT06563895 · updated
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- No phase
- Ages 18 and older
- Female participants
- Sponsor
- Michigan State University
- Recruiting in
- Corunna · Flint · Gaylord · and 5 more U.S. locations
- Registry record
- NCT07213284 · updated
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Observational
- Ages 60 to 90
- All sexes
- Sponsor
- GAP Innovations, PBC
- Recruiting in
- Farmington Hills
- Registry record
- NCT06584357 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Michigan on ClinicalTrials.gov.
Ask about studies in Michigan
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections